Willem-Pieter Brouwer

28PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersMetabolic medicineMajor global burdens of diseaseMedical molecular engineering of nucleic acids and proteinsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 01, 2026
Senolytics dasatinib and quercetin in metabolic dysfunction-associated steatohepatitis: a proof-of-principle randomized, controlled trial.

|Mar 23, 2026
Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH).

Laurens A Van Kleef, Maurice Michel, Naim Alkhouri

|Nov 29, 2025
Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt.

Michelle Spaan, Ellen Werner, Willemijn Dijkstra

|Nov 06, 2025
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER).

Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim

|Sep 09, 2025
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease.

Lesley A Patmore, Ivana Carey, Jordan J Feld

|Jul 23, 2025
A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population Setting.

Laurens A van Kleef, Maurice Michel, Mesut Savas

Pageof 5

Frequent Collaborators

8 joint publications

Milan J Sonneveld

7 joint publications

Laurens A van Kleef

7 joint publications

Robert J de Knegt

4 joint publications

Margo J H van Campenhout